Examkin

Question

Difficulty: HardBias, Confounding, and Validity

A state health informatics registry is utilized to evaluate the real-world effectiveness of a newly approved non-steroidal mineralocorticoid receptor antagonist (MRA) versus standard angiotensin receptor blockers (ARBs) in preventing incident end-stage renal disease (ESRD) among patients with type 2 diabetes. The research group is primarily concerned about confounding by indication; specifically, physicians may preferentially prescribe the novel MRA to patients with significantly higher baseline proteinuria, a factor that independently accelerates progression to ESRD.

To appropriately address baseline proteinuria as a confounding variable, which of the following methodological strategies are valid approaches? (Select all that apply)

  1. Restricting study inclusion to only those individuals with a baseline urine albumin-to-creatinine ratio strictly between 30 and 300 mg/g.Answer
  2. Incorporating the baseline 24-hour urine protein excretion rate as an independent covariate within a multivariable Cox proportional hazards model.Answer
  3. C
    Reporting separate, stratum-specific hazard ratios to demonstrate that the medication's impact on ESRD risk differs in magnitude between the low and high proteinuria groups.
  4. D
    Applying an independent samples Student's t-test to compare the mean time to dialysis initiation between the two treatment cohorts.
  5. E
    Computing the positive predictive value of MRA therapy for averting ESRD, adjusted for the state-wide prevalence of diabetic nephropathy.

Answer

The valid approaches to control for confounding in this scenario are restricting the study population to a specific range of proteinuria and adjusting for proteinuria using a multivariable Cox proportional hazards model.
Confounding by indication occurs when a baseline clinical characteristic (proteinuria) influences both treatment selection and the risk of the outcome (ESRD). To determine the independent effect of the MRA, this confounding must be neutralized. Restriction (limiting the study to patients with similar proteinuria levels) is a valid design-phase technique that removes the variation in the confounder. Multivariable Cox proportional hazards regression is a valid analysis-phase technique that mathematically adjusts the risk estimate for the presence of the covariate while correctly handling the time-to-event data.

Step-by-Step Solution

1
Identify the primary methodological threat described in the scenario.
The scenario describes confounding by indication, where baseline proteinuria affects both the likelihood of receiving the new MRA and the risk of the outcome (ESRD).
Recognizing the specific bias dictates which methodological tools are appropriate for mitigation.
2
Evaluate design-phase strategies for controlling confounding.
Restriction limits enrollment to a specific category of the confounder (e.g., only microalbuminuria), effectively eliminating the confounder's variation within the study.
If all subjects have the same level of the confounding variable, it can no longer distort the exposure-outcome relationship.
3
Evaluate analysis-phase strategies for controlling confounding.
Multivariable regression models (such as Cox proportional hazards for survival data) can include the confounder as a covariate, mathematically adjusting the primary risk estimate.
This allows researchers to estimate the independent effect of the medication while holding the confounder constant.
4
Differentiate confounding control from effect modification assessment.
Reporting stratum-specific estimates specifically to show that the effect sizes are different is the definition of identifying an effect modifier, not controlling a confounder.
Confounding is a nuisance variable to be eliminated (resulting in one adjusted estimate), whereas effect modification is a biological reality to be described (resulting in separate estimates).

Key Concept

Methods for controlling confounding in observational studies (Restriction, Matching, Stratification, Multivariable Regression).
Rate this question

Topics

Bias, Confounding, and Validity

More questions from this topic